Mark A. Preston - Publications, H-index & Citations

Mark A. Preston

harvard medical school

38H指数

275论文数

6.0K被引数

收录论文 82

发表时间

Publisher Correction: Chemical efflux imaging using an annular nanosensor array for in situ bladder cancer detection Publisher Correction: 使用环形纳米传感器阵列进行化学外流成像以实现原位膀胱癌检测

Nature Nanotechnology

IF34.9

2026-07-06

PREAI

Wonjun Yim; Hohyung Kang; Byung Ha Kang; Maeve E. McGinnis; Marco Machado; Xun Gong; Volodymyr Koman; Gabriel Sánchez-Velázquez; Xiaojia Jin; Zitang Wei; Mark A. Preston; Daniel A. Wollin; Michael S. Strano

Chemical efflux imaging using an annular nanosensor array for in situ bladder cancer detection 使用环形纳米传感器阵列进行化学外排成像以进行原位膀胱癌检测

Nature Nanotechnology

IF34.9

2026-05-27

PREAI

ALVIMOPAN IN PATIENTS UNDERGOING RADICAL CYSTECTOMY AND URINARY DIVERSION ON A STANDARDIZED ENHANCED RECOVERY AFTER SURGERY PROTOCOL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 标准化快速康复外科方案下接受根治性膀胱切除术和尿流改道患者中的阿维莫泮：一项随机、双盲、安慰剂对照试验

Journal of Urology

IF6.8

2026-05-01

PREAI

Yim, Kendrick; Lukas, Vanessa; Liu, Xiu; Berger, Alexandra; Philip, Rieya; Vasavada, Anjali; Barylak, Martin; Mossanen, Matthew; Clinton, Timothy; Steele, Graeme; Trinh, Quoc-Dien; Chang, Steven; Kibel, Adam; Stopfkuchen-Evans, Matias; Urman, Richard; Preston, Mark A.

TAR-200 plus cetrelimab versus cetrelimab monotherapy as neoadjuvant therapy in patients with muscle-invasive bladder cancer who are ineligible for or decline neoadjuvant cisplatin-based chemotherapy (SunRISe-4): interim analysis of a randomised, open-label phase 2 trial TAR-200联合西特雷利单抗与西特雷利单抗单药治疗作为不适合或拒绝新辅助顺铂为基础化疗的肌层浸润性膀胱癌患者的新辅助治疗（SunRISe-4）：一项随机、开放标签Ⅱ期试验的期中分析

lancet oncology

IF0

2025-08-27

PREAI

Andrea Necchi; Félix Guerrero-Ramos; Paul L Crispen; Bernardo Herrera-Imbroda; Rohan Garje; Thomas Powles; Charles C Peyton; Benjamin Pradere; Ja Hyeon Ku; Neal Shore; Martin Bögemann; Mark A Preston; Evanguelos Xylinas; Cristina Sanchez de Llano; Mohamad Hasan; Hind Stitou; Sumeet Bhanvadia; Hussein Sweiti; Sarah P Psutka

Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancer 格莱森评分在预测转移性和致死性前列腺癌方面的长期性能

American Journal of Epidemiology

IF4.8

2025-04-29

PREAI

Zhike Lin; Konrad H Stopsack; Michelangelo Fiorentino; J Bailey Vaselkiv; Travis Gerke; Andreas Pettersson; Richard Flavin; Sinead Flanagan; Philip W Kantoff; Tamara L Lotan; Mark A Preston; Stephen P Finn; Massimo Loda; Kathryn L Penney; Lorelei A Mucci

A pilot study of [18F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy 一项关于[18F]F-fluciclovine正电子发射断层扫描/计算机断层扫描在根治性膀胱切除术前的肌层浸润性膀胱癌分期作用的初步研究

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

IF7.6

2025-04-21

PREAI

Ng, Thomas S. C.; Liu, Mofei; Robertson, Matthew; Konik, Arda; Cheng, Su Chun; Bakht, Martin K.; Harrington, Kristen; Wolanski, Andrew; Gilbert, Lauren; Preston, Mark; Mossanen, Matthew; Beltran, Himisha; Hirsch, Michelle S.; Sonpavde, Guru; Jacene, Heather A.

Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients 达鲁他胺加雄激素剥夺疗法: ARASEC和历史临床试验患者的倾向评分匹配

FUTURE ONCOLOGY

IF2.6

2025-04-01

OAAI

McKay, Rana R.; Ross, Ashley E.; Preston, Mark A.; Gregg, Justin R.; Salami, Simpa S.; Littleton, Natasha; Constantinovici, Niculae; Srinivasan, Shankar; Verholen, Frank; Shore, Neal D.

Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non–muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies 肿瘤分期对接受保留膀胱疗法的高级别卡介苗无应答的非肌层浸润性膀胱癌患者肿瘤学结局的影响

European Urology Focus

IF5.6

2025-02-07

PREAI

Drupad Annapureddy; Jacob I. Taylor; Ashish M. Kamat; Michael A. O’Donnell; Jeffrey Howard; Wei Shen Tan; Ian M. McElree; Facundo Davaro; Kendrick Yim; Stephen Harrington; Elizabeth Dyer; Anna J. Black; Pratik Kanabur; Mathieu Roumiguié; Seth Lerner; Peter C. Black; Jay D. Raman; Mark A. Preston; Gary Steinberg; William Huang; Roger Li; Vignesh T. Packiam; Solomon L. Woldu; Yair Lotan

Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer 在卡介苗无反应的非肌肉浸润性膀胱癌中，保留膀胱疗法与根治性膀胱切除术的长期结果

BJU INTERNATIONAL

IF4.4

2024-08-25

OAAI

Taylor, Jacob I.; Kamat, Ashish M.; O'Donnell, Michael A.; Annapureddy, Drupad; Howard, Jeffrey; Tan, Wei Shen; McElree, Ian; Davaro, Facundo; Yim, Kendrick; Harrington, Stephen; Dyer, Elizabeth; Black, Anna J.; Kanabur, Pratik; Roumiguie, Mathieu; Lerner, Seth; Black, Peter C.; Raman, Jay D.; Preston, Mark A.; Steinberg, Gary; Huang, William; Li, Roger; Packiam, Vignesh T.; Woldu, Solomon L.; Lotan, Yair

Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer

JOURNAL OF UROLOGY

IF6.8

2024-06-01

OAAI

Rumpf, Florian; Plym, Anna; Vaselkiv, Jane B.; Penney, Kathryn L.; Preston, Mark A.; Kibel, Adam S.; Mucci, Lorelei A.; Salari, Keyan

SMOKING STATUS IS ASSOCIATED WITH POOR MENTAL HEALTH IN BLADDER CANCER PATIENTS AND SURVIVORS

JOURNAL OF UROLOGY

IF6.8

2024-05-01

PREAI

Alkhatib, Khalid Y.; Koelker, Mara; Nolazco, Jose I.; Steele, Graeme; Preston, Mark A.; Harmatz, Ian Mitchell; Clinton, Timothy N.; Lee, Daniel J.; Chang, Steve L.; Bivalacqua, Trinity J.; Gore, John L.; Guzzo, Thomas; Kibel, Adam S.; Trinh, Quoc-Dien; Mossanen, Matthew

Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-05-01

OAAI

Flaig, Thomas W.; Spiess, Philippe E.; Abern, Michael; Agarwal, Neeraj; Bangs, Rick; Buyyounouski, Mark K.; Chan, Kevin; Chang, Sam S.; Chang, Paul; Friedlander, Terence; Greenberg, Richard E.; Guru, Khurshid A.; Herr, Harry W.; Hoffman-Censits, Jean; Kaimakliotis, Hristos; Kishan, Amar U.; Kundu, Shilajit; Lele, Subodh M.; Mamtani, Ronac; Mian, Omar Y.; Michalski, Jeff; Montgomery, Jeffrey S.; Parikh, Mamta; Patterson, Anthony; Peyton, Charles; Plimack, Elizabeth R.; Preston, Mark A.; Richards, Kyle; Sexton, Wade J.; Siefker-Radtke, Arlene O.; Stewart, Tyler; Sundi, Debasish; Tollefson, Matthew; Tward, Jonathan; Wright, Jonathan L.; Cassara, Carly J.; Gurski, Lisa A.

Comparative effectiveness of cystoscopy surveillance strategies on mortality in non-muscle invasive bladder cancer: A target trial emulation using real-world data

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

McGee, Emma E.; de Albeniz, Xabier Garcia; Eliassen, A. Heather; Yim, Kendrick; Dickerman, Barbra A.; Preston, Mark A.; Hernan, Miguel

Implications of Delayed Testosterone Recovery in Patients with Prostate Cancer 前列腺癌患者睾酮恢复延迟的意义

EUROPEAN UROLOGY OPEN SCIENCE

IF4.5

2024-02-01

OAAI

Preston, Mark A.; Hong, Agnes; Dufour, Robert; Marden, Jessica R.; Kirson, Noam Y.; Gatoulis, Sergio C.; Kongara, Serena; Gandhi, Raj; Morgans, Alicia K.

Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial

CANCER

IF5.1

2024-01-01

PREAI

Mckay, Rana R.; Xie, Wanling; Yang, Xiaoyu; Acosta, Andres; Rathkopf, Dana; Laudone, Vincent P.; Bubley, Glenn J.; Einstein, David J.; Chang, Peter; Wagner, Andrew A.; Kane, Christopher J.; Preston, Mark A.; Kilbridge, Kerry; Chang, Steven L.; Choudhury, Atish D.; Pomerantz, Mark M.; Trinh, Quoc-Dien; Kibel, Adam S.; Taplin, Mary-Ellen

Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder Cancer 膀胱癌根治性膀胱切除术关键步骤的循证分析

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-10-30

OAAI

D'Andrea, Vincent D.; Melnick, Kevin; Yim, Kendrick; Ernandez, John; Onochie, Nnamdi; Clinton, Timothy N.; Steele, Graeme S.; Preston, Mark A.; Kibel, Adam S.; Mossanen, Matthew

Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial

JOURNAL OF UROLOGY

IF6.8

2023-10-01

OAAI

Yim, Kendrick; Ma, Chaoran; Carlsson, Sigrid; Lilja, Hans; Mucci, Lorelei; Penney, Kathryn; Kibel, Adam S.; Eggener, Scott; Preston, Mark A.

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

EUROPEAN UROLOGY

IF25.2

2023-10-01

OAAI

Surasi, Devaki Shilpa; Eiber, Matthias; Maurer, Tobias; Preston, Mark A.; Helfand, Brian T.; Josephson, David; Tewari, Ashutosh K.; Somford, Diederik M.; Rais-Bahrami, Soroush; Koontz, Bridget F.; Bostrom, Peter J.; Chau, Albert; Davis, Phillip; Schuster, David M.

Prostate cancer screening in African American men: a review of the evidence

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2023-09-15

OAAI

Kensler, Kevin H.; Johnson, Roman; Morley, Faith; Albrair, Mohamed; Dickerman, Barbra A.; Gulati, Roman; Holt, Sarah K.; Iyer, Hari S.; Kibel, Adam S.; Lee, Jenney R.; Preston, Mark A.; Vassy, Jason L.; Wolff, Erika M.; Nyame, Yaw A.; Etzioni, Ruth; Rebbeck, Timothy R.

Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review 膀胱切除术或支架移除前抗生素预防与感染并发症之间的关系: 系统评价

EUROPEAN UROLOGY FOCUS

IF5.6

2023-07-01

OAAI

Antonelli, Luca; Sebro, Kirby; Lahmar, Abdelilah; Black, Peter C.; Ghodoussipour, Saum; Hamilton-Reeves, Jill M.; Shah, Jay; Thoft, Jensen Bente; Lerner, Seth Paul; Llorente, Carlos; Lucca, Ilaria; Preston, Mark A.; Psutka, Sarah P.; Sfakianos, John P.; Lauridsen, Susanne Vahr; Williams, Stephen B.; Catto, James; Djaladat, Hooman; Kassouf, Wassim; Loftus, Katherine; Daneshmand, Siamak; Fankhauser, Christian D.

研究方向